Forbes -
19 Jan 2021 16:00

Johnson & Johnson is developing one of the most closely watched Covid-19 vaccines, considering that it is a single-dose shot that should be relatively easy to distribute. Here's a quick rundown on the recent developments for the vaccine. Based on data from the phase 1/2 trials of 805 participants...
Share this Article
Comment on this Article
Please to comment